{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:11:09Z","timestamp":1765282269938,"version":"3.46.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clnu.2025.11.013","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:37:09Z","timestamp":1763771829000},"page":"223-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Does parenteral Omega-3 fatty acid administration increase the risk of atrial fibrillation? An analysis of the current evidence"],"prefix":"10.1016","volume":"55","author":[{"given":"Wolfgang H.","family":"Hartl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Pirlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Elke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Stoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-1912","authenticated-orcid":false,"given":"Christian","family":"von Loeffelholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2025.11.013_bib1","unstructured":"https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-25-28-september-2023 (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib2","unstructured":"https:\/\/www.ema.europa.eu\/de\/documents\/psusa\/omega-3-acid-ethyl-esters-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00010312-202301_de.pdf date of last access: (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib3","unstructured":"https:\/\/www.gov.uk\/drug-safety-update\/omega-3-acid-ethyl-ester-medicines-omacor-slash-teromeg-1000mg-capsules-dose-dependent-increased-risk-of-atrial-fibrillation-in-patients-with-established-cardiovascular-diseases-or-cardiovascular-risk-factors (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib4","unstructured":"https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/EN\/RHB\/2023\/rhb-omega-3-fettsaeure.html?nn=966164 (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib5","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/202057s035lbl.pdf date of last access: 16.07.2025(Accessed 16 July 2025)."},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13054-022-03997-z","article-title":"Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN)","volume":"26","author":"Matejovic","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.clnu.2025.11.013_bib7","unstructured":"https:\/\/www.iqvia.com\/solutions\/commercialization\/commercial-analytics-and-consulting\/brand-strategy-and-management\/analytics-link-ecosystem (Accessed 5 July 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib8","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/207648s005lbl.pdf (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib9","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/210589s003lbl.pdf (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib10","unstructured":"https:\/\/docetp.mpa.se\/LMF\/Lipoplus%20emulsion%20for%20infusion%20ENG%20SmPC%09001bee807a5a8a.pdf (Accessed 3 February 2025)."},{"key":"10.1016\/j.clnu.2025.11.013_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2016.07.001","article-title":"The impact of an ome-ga-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients","volume":"112","author":"Hall","year":"2016","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1016\/j.clnu.2025.11.013_bib12","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.clnu.2018.12.010","article-title":"Four-oil intravenous lipid emulsion effect on plasma fatty acid composition, inflammatory markers and clinical outcomes in acutely ill patients: a randomised control trial (Foil fact)","volume":"38","author":"Donoghue","year":"2019","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1016\/j.clnu.2025.11.013_bib13","article-title":"Omega-3 fatty acids as antiarrhythmic drugs: upstream target modulators affecting acute and long-term pathological alterations in cardiac structure and function","volume":"5","author":"Driscoll","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.clnu.2025.11.013_bib14","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/omega-3-acid-ethyl-esters-containing-medicinal-products-oral-use-secondary-prevention-after-myocardial-infarction (Accessed 3 February 2025)."},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2047487316676037","volume":"24","author":"Gorenek","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"24","key":"10.1016\/j.clnu.2025.11.013_bib16","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American college of Cardiology\/American Heart Association task force on clinical practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13054-024-05053-4","article-title":"The role of lipid emulsions containing omega-3 fatty acids for medical and surgical critical care patients","volume":"28","author":"Stoppe","year":"2024","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.clnu.2025.11.013_bib19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.clnu.2023.07.011","article-title":"ESPEN practical and partially revised guideline: clinical nutrition in the intensive care unit","volume":"42","author":"Singer","year":"2023","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jpen.2267","article-title":"Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the American Society for Parenteral and Enteral Nutrition","volume":"46","author":"Compher","year":"2022","journal-title":"J Parenter Enter Nutr"},{"issue":"4","key":"10.1016\/j.clnu.2025.11.013_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nutos.2025.01.004","article-title":"Lipids in parenteral nutrition \u2013 expert consensus statements: translating guidelines into clinical practice","volume":"60","author":"Martindale","year":"2025","journal-title":"Clin Nutr Open Sci"},{"key":"10.1016\/j.clnu.2025.11.013_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0148607115621863","article-title":"Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American Society for parenteral and enteral nutrition (A.S.P.E.N.)","volume":"40","author":"McClave","year":"2016","journal-title":"J Parenter Enter Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"REDUCE-IT investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clnu.2025.11.013_bib24","first-page":"CD003177","article-title":"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease","volume":"3","author":"Abdelhamid","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2025.11.013_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100997","article-title":"Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic re-view and meta-analysis","volume":"38","author":"Khan","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"Supplement_1","key":"10.1016\/j.clnu.2025.11.013_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwac056.186","article-title":"The most important safety risk of fish oil from the latest meta-analysis?","volume":"29","author":"Yan","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.clnu.2025.11.013_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10557-022-07379-z","article-title":"Efficacy and safety of Omega-3 fatty acids in the prevention of cardiovascular disease: a systematic review and meta-analysis","volume":"38","author":"Yan","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"issue":"25","key":"10.1016\/j.clnu.2025.11.013_bib28","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.121.055654","article-title":"Effect of long-term marine \u0277 -3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis","volume":"144","author":"Gencer","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.clnu.2025.11.013_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10557-021-07204-z","article-title":"Association Be-tween Omega-3 fatty acid treatment and atrial fibrillation in cardiovascular outcome trials: a sys-tematic review and meta-analysis","volume":"35","author":"Jia","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.clnu.2025.11.013_bib30","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/ehjcvp\/pvab008","article-title":"Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials","volume":"7","author":"Lombardi","year":"2021","journal-title":"Eur Heart J Cardi-ovasc Pharmacother"},{"issue":"6","key":"10.1016\/j.clnu.2025.11.013_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.123.065520","article-title":"RESPECT-EPA investigators. Randomized trial for evaluation in secondary prevention efficacy of combination therapy-statin and eicosapentaenoic acid (RESPECT-EPA)","volume":"150","author":"Miyauchi","year":"2024","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.clnu.2025.11.013_bib32","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.clnu.2025.11.013_bib33","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.121.057464","article-title":"Fish oil supplements may increase the risk for atrial fibrillation: what does this mean?","volume":"144","author":"Samuel","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2025.11.013_bib34","article-title":"Omega-3 and risk of atrial fibrillation: vagally-mediated double-edged sword","volume":"30","author":"O'Keefe","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.clnu.2025.11.013_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amjcard.2014.10.022","article-title":"Effect of omega-three poly-unsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation","volume":"115","author":"Vanderbilt","year":"2015","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.clnu.2025.11.013_bib36","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.18632\/oncotarget.23783","article-title":"A meta-analysis on Omega-3 supplements in pre-venting recurrence of atrial fibrillation","volume":"9","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.clnu.2025.11.013_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.123.065769","article-title":"Omega-3 fatty acids and arrhythmias","volume":"150","author":"Marcus","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clnu.2025.11.013_bib38","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.ijcard.2013.03.053","article-title":"Effects of high dose intravenous fish oil on human atrial electrophysiology: implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation","volume":"168","author":"Kumar","year":"2013","journal-title":"Int J Cardiol"},{"issue":"14","key":"10.1016\/j.clnu.2025.11.013_bib39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.121.058596","article-title":"Fishing for links between Omega-3 fatty acids and atrial fibrillation","volume":"145","author":"Fatkin","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ejcn.2013.215","article-title":"U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery","volume":"68","author":"Metcalf","year":"2014","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2025.11.013_bib41","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ajcn\/85.5.1222","article-title":"Effects of fish-oil supplementation on myocardial fatty acids in humans","volume":"85","author":"Metcalf","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.clnu.2025.11.013_bib42","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/europace\/euu019","article-title":"A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation\/atrial flutter-a Danish cohort study","volume":"16","author":"Rix","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.clnu.2025.11.013_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2024.102633","article-title":"The efficacy and acceptability of anti-inflammatory omega-3 polyunsaturated fatty acid supplements in sepsis management: a network meta-analysis of randomized controlled trials","volume":"202","author":"Tseng","year":"2024","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13054-022-03896-3","article-title":"Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients","volume":"26","author":"Notz","year":"2022","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s13054-020-03356-w","article-title":"Ome-ga-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis","volume":"24","author":"Pradelli","year":"2020","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.clnu.2025.11.013_bib46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.clnu.2013.02.010","article-title":"Fatty acids in plasma, white and red blood cells, and tissues after oral or intravenous administration of fish oil in rats","volume":"32","author":"Barros","year":"2013","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2025.11.013_bib47","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.clnu.2019.03.040","article-title":"Pharmacokinetics of omega-3 fatty acids in patients with severe sepsis compared with healthy volunteers: a prospective cohort study","volume":"39","author":"Parikh","year":"2020","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/bjs.1800700113","article-title":"The effect of sepsis on the oxidation of carbohydrate and fat","volume":"70","author":"Stoner","year":"1983","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.clnu.2025.11.013_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00003246-199005000-00001","article-title":"Influence of parenteral nutrition on rates of net sub-strate oxidation in severe trauma patients","volume":"18","author":"Jeevanandam","year":"1990","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000658-198001000-00008","article-title":"Influence of total parenteral nutrition on fuel utilization in injury and sepsis","volume":"191","author":"Askanazi","year":"1980","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.clnu.2025.11.013_bib51","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0148607111427040","article-title":"Influence of parenteral nutrition delivery system on the development of bloodstream infections in critically ill patients: an international, multicenter, prospective, open-label, controlled study--EPICOS study","volume":"36","author":"Pontes-Arruda","year":"2012","journal-title":"J Parenter Enter Nutr"},{"issue":"10","key":"10.1016\/j.clnu.2025.11.013_bib52","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archsurg.1984.01390220011003","article-title":"Altered hormonal activity in severely ill patients after injury or sepsis","volume":"119","author":"Baue","year":"1984","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.clnu.2025.11.013_bib53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BCR.0b013e31820aafcf","article-title":"Changes in cardiac physiology after severe burn injury","volume":"32","author":"Williams","year":"2011","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.clnu.2025.11.013_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10840-018-0315-5","article-title":"N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review","volume":"51","author":"Wang","year":"2018","journal-title":"J Intervent Card Electrophysiol"},{"issue":"3","key":"10.1016\/j.clnu.2025.11.013_bib55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clnu.2016.05.013","article-title":"Omega-3 polyunsaturated fatty acids in cardiac surgery patients: an updated systematic review and meta-analysis","volume":"36","author":"Langlois","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2025.11.013_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2018.10.020","article-title":"Role of inflammatory signalling in atrial fibrillation","volume":"287","author":"Scott","year":"2019","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.clnu.2025.11.013_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100770","article-title":"Inflammatory markers after supplementation with marine n-3 or plant n-6 PUFAs: a randomized double-blind crossover study","volume":"66","author":"Grytten","year":"2025","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.clnu.2025.11.013_bib58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.plefa.2012.12.004","article-title":"Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients","volume":"88","author":"Harris","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clnu.2025.11.013_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-006-1392-2","article-title":"The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes","volume":"40","author":"Sands","year":"2005","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.clnu.2025.11.013_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S0029665124000181","article-title":"Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women","volume":"84","author":"Hall","year":"2025","journal-title":"Proc Nutr Soc"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425003012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561425003012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:53:35Z","timestamp":1765281215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561425003012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"alternative-id":["S0261561425003012"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2025.11.013","relation":{},"ISSN":["0261-5614"],"issn-type":[{"type":"print","value":"0261-5614"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does parenteral Omega-3 fatty acid administration increase the risk of atrial fibrillation? An analysis of the current evidence","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2025.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}